HCVAdvocate Newsletter Links
Hepatitis C May Reduce EPO Requirements
Lubbock health officials say Nev. hepatitis problem being averted here
SciClone Hosts Thymalfasin Symposium at Asian Pacific Association for the Study of the Liver
Contest seeks to break silence; Poster design competition aims to raise hep C awareness
Valeant Pharmaceuticals Reports Encouraging Phase IIb Results at Treatment Week 12 for Taribavirin
GPs need new liver function guidance say experts
Management of Patients with Concurrent HBV and HCV Infection
Inovio Biomedical Reveals Safety Results Of Tripep's ChronVac-C Delivered Using Inovio's Electroporation Delivery Systems
FDA Halts Studies of Hepatitis Vaccine From Merck and Dynavax Over Safety Worries
Vertex Pharmaceuticals and Tibotec Announce Start of Phase 3 'ADVANCE' Study with Telaprevir in Treatment-Naive, Genotype 1 HCV Patients
OctoPlus announces publication of Phase I Locteron results in the Journal of Interferon and Cytokine Research
Gilead's Viread Gets Hepatitis B Nod
China's Hepatitis B carriers face gloomy future
Hepatitis B Foundation Testifies Before Congressional Appropriation Committee and Urges More Federal Funding for Hepatitis B
Presidio Pharmaceuticals buys rights to hepatitis C program
Hepatitis Open Forum Scheduled For Monday, March 24th
Criminal Charges Could Void Victim Awards in Hep C Lawsuits
New Method Disrupts Hepatitis C Virion Production
Ex-nurse accused of infecting patients with hepatitis
